ABT-202 (AnBogen Therapeutics)

N/A

Report date: 2025/02/18 11:53:01
NME

Base Information

Drug NameABT-202 (AnBogen Therapeutics)
Drug Alias NameABT-202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12D inhibitors
TargetsKRAS G12D
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnbogen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnbogen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A